9.71 USD
+0.69 (+7.65%)
9.75 USD
+0.04 (+0.41%)
ChartMill assigns a Buy % Consensus number of 80% to FGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 43.86. This target is 351.7% above the current price.
- FGEN was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FGEN.
- In the previous month the buy percentage consensus was at a similar level.
- FGEN was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-08 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-06-27 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2023-06-27 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-06-26 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-06-26 | Stifel | Downgrade | Buy -> Hold |
| 2023-06-26 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2023-06-26 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-06-02 | Stifel | Upgrade | Hold -> Buy |
| 2023-02-28 | Cowen & Co. | Maintains | Market Perform |
| 2023-02-23 | Goldman Sachs | Maintains | Sell |
| 2023-02-21 | Goldman Sachs | Maintains | Sell |
| 2023-01-31 | William Blair | Upgrade | Market Perform -> Outperform |
| 2023-01-26 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2023-01-05 | B of A Securities | Upgrade | Neutral -> Buy |
| 2022-11-08 | Goldman Sachs | Maintains | Sell |
| 2022-05-24 | Goldman Sachs | Maintains | Sell |
| 2022-03-01 | Goldman Sachs | Maintains | Sell |
| 2021-09-22 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2021-08-20 | Raymond James | Upgrade | Underperform -> Market Perform |
| 2021-08-10 | SVB Leerink | Maintains | Outperform |
| 2021-07-16 | Stifel | Downgrade | Buy -> Hold |
| 2021-07-16 | B of A Securities | Downgrade | Buy -> Neutral |
| 2021-04-07 | Mizuho | Downgrade | Buy -> Neutral |
| 2021-04-07 | SVB Leerink | Maintains | Outperform |
| 2021-04-07 | JP Morgan | Upgrade | Underweight -> Neutral |
FIBROGEN INC / FGEN FAQ
What is the average price target for FIBROGEN INC (FGEN) stock?
8 analysts have analysed FGEN and the average price target is 43.86 USD. This implies a price increase of 351.7% is expected in the next year compared to the current price of 9.71.
What is the consensus rating for FIBROGEN INC (FGEN) stock?
The consensus rating for FIBROGEN INC (FGEN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for FIBROGEN INC stock?
The number of analysts covering FIBROGEN INC (FGEN) is 8.